GTDCX | VEMAX | GTDCX / VEMAX | |
Total Expense Ratio | 2.14 | 0.13 | 1,646% |
Annual Report Gross Expense Ratio | 2.14 | 0.13 | 1,646% |
Fund Existence | 27 years | 19 years | - |
Gain YTD | 17.784 | 21.144 | 84% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 3000 | 33% |
Min. Initial Investment IRA | 250 | N/A | - |
Net Assets | 1.26B | 130B | 1% |
Annual Yield % from dividends | 0.18 | 2.65 | 7% |
Returns for 1 year | 8.14 | 13.70 | 59% |
Returns for 3 years | 39.48 | 53.21 | 74% |
Returns for 5 years | 4.55 | 38.74 | 12% |
Returns for 10 years | 71.03 | 93.76 | 76% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FTXH | 27.67 | 0.37 | +1.35% |
First Trust Nasdaq Pharmaceuticals ETF | |||
RSPG | 81.56 | 0.99 | +1.23% |
Invesco S&P 500® Equal Weight Energy ETF | |||
GSUS | 91.83 | 0.53 | +0.58% |
Goldman Sachs MarketBeta US Equity ETF | |||
EVIM | 52.51 | 0.02 | +0.03% |
Eaton Vance Intermediate Muncpl Inc ETF | |||
EBIT | 33.93 | N/A | N/A |
Harbor AlphaEdge Small Cap Earners ETF |